Switch to:
More From Other Websites
Amgen Opens Nomination Process For LabCentral Residency Sep 26 2016
Amgen Opens Nomination Process For LabCentral Residency Sep 26 2016
Amgen And UCB Announce U.S. FDA Acceptance Of Biologics License Application For Romosozumab Sep 26 2016
UCB and Amgen announce U.S. FDA acceptance of biologics licence application for Romosozumab Sep 26 2016
Wall Street Sells Off on Worries Over Clinton-Trump Showdown Sep 26 2016
4:01 pm Amgen and UCB announce that the FDA has accepted for review the Biologics license... Sep 26 2016
Amgen And UCB Announce U.S. FDA Acceptance Of Biologics License Application For Romosozumab Sep 26 2016
Stocks Fall Ahead of Clinton-Trump Debate, Crude Rallies Sep 26 2016
As Humira Alternative Gets FDA Approval, Is Abbvie in Trouble? Sep 26 2016
Amgen’s Venture Funding Initiative (AMGN) Sep 26 2016
How Much Will Consumers Save on New Humira Biosimilar? Sep 26 2016
3 Trades to Blaze a Trail Higher in Amgen Sep 26 2016
Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval Sep 26 2016
FDA Approves Amgen's Biosimilar Version of Humira Sep 23 2016
FDA Approves Amgen's AMJEVITA™ (Adalimumab-Atto) For Treatment Of Seven Inflammatory Diseases Sep 23 2016
FDA approves lower-cost alternative to biotech drug Humira Sep 23 2016
FDA approves lower-cost alternative to biotech drug Humira Sep 23 2016
FDA Approves Amgen's AMJEVITA™ (Adalimumab-Atto) For Treatment Of Seven Inflammatory Diseases Sep 23 2016
U.S. FDA approves Amgen's copy of AbbVie arthritis drug Humira Sep 23 2016
Will Amgen (AMGN) Stock Be Helped By FDA Approval of Humira Biosimilar? Sep 23 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK